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Background: The human minichromosome maintenance (hMCM) complex is an important component of the DNA
replication apparatus.
Results: After being produced in Escherichia coli, hMCM has ATPase and DNA helicase activity and undergoes a conforma-
tional change when bound to DNA.
Conclusion: Recombinant hMCM is functional in vitro.
Significance: hMCM provides an important tool for the biochemical reconstitution of the human replicative helicase.
ATP-dependent DNA unwinding activity has been demon-
strated for recombinant archaeal homohexamericminichromo-
some maintenance (MCM) complexes and their yeast hetero-
hexameric counterparts, but in higher eukaryotes such as
Drosophila, MCM-associated DNA helicase activity has been
observed only in the context of a co-purified Cdc45-MCM-
GINS complex. Here, we describe the production of the recom-
binant humanMCM (hMCM) complex in Escherichia coli. This
protein displays ATP hydrolysis activity and is capable of
unwinding duplex DNA. Using single-particle asymmetric EM
reconstruction, we demonstrate that recombinant hMCM
forms a hexamer that undergoes a conformational change when
bound to DNA. Recombinant hMCM produced without post-
translationalmodifications is functional in vitro andprovides an
important tool for biochemical reconstitutionof thehuman rep-
licative helicase.
DNA replication is fundamental to the proliferation of all
cells and, as such, has been the subject of intense scrutiny over
many years. Although this work has demonstratedmany unify-
ing similarities among all eukaryotes with regard to DNA rep-
lication, it has also become obvious that there are a number of
differences in the details regarding these systems. Significantly,
one of the main model organisms for eukaryotic DNA replica-
tion, the yeast Saccharomyces cerevisiae, has a closed mitosis
that requires replication proteins to cross the nuclear envelope
in a manner not required in other eukaryotes (1). The
minichromosome maintenance (MCM)7 proteins are a good
example of such proteins, and S. cerevisiaeMCMproteins pos-
sess insertions to cater to this requirement (Table 1). Themod-
els used to study replication in Xenopus and Drosophila are
egg-based and contain unusually high levels of (likely preas-
sembled) replication complexes not normally seen in post-em-
bryonic systems (2). Data fromhuman tissue culture studies are
basedmainly on transformed cells, which probably donot accu-
rately reflect the cell cycle controls in primary explants (3).
Thus, the use of recombinant components, which may more
accurately reconstitute robust DNA helicase activity biochem-
ically, is of significant interest in understanding human DNA
replication processes.
The MCM complex is essential for DNA replication in
eukaryotes and archaea, where it is believed to act as the repli-
cative DNA helicase (reviewed in Ref. 4). Homohexameric
archaeal MCM complexes have provided useful models for
studyingDNAhelicase activity (5, 6). The production of a num-
ber of crystal structures has facilitated mapping of key enzyme
residues and provided insight into the molecular mechanisms
utilized in DNA unwinding and translocation (7, 8). In addition
to its essential role in DNA replication, the heterohexameric
eukaryotic MCM2–7 complex has been implicated in DNA
damage responses, checkpoint signaling, transcription, and
chromatin remodeling (9–12).
Isolation of intact functional MCM heterohexamers has
proved challenging. Functional MCM complexes purified
from Xenopus egg extracts using a replication licensing fac-
tor assay demonstrated an additional requirement for Cdt1
in MCM chromatin loading (13, 14). A Cdc45-MCM-GINS
complex with DNA helicase activity has been isolated from
Drosophila egg extracts (15). MCM function is post-transla-
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tionally modulated in vivo by phosphorylation, although this
is not essential for replication elongation (16). The presence
of inhibitory phosphorylations might explain why some
purified MCM complexes produced in eukaryotic expres-
sion systems do not demonstrate significant helicase activ-
ity. Current methods for MCM2–7 complex analysis rely on
purification from yeast or insect cells, potentially complicat-
ing the interpretation of results, as the purified MCM2–7
complexes may have been post-translationally modified
prior to purification.
We report the development of a bacterial expression pro-
tocol that allows the production of a recombinant human
MCM2–7 (hMCM) complex in Escherichia coli. Our hMCM
complex exhibits DNA unwinding and ATP hydrolysis with a
different salt sensitivity from that reported for the yeast com-
plex (17). Structures of the protein obtained by EM methods
show that hMCM forms an asymmetric hexameric complex
that undergoes a conformational change in the presence of a
forked DNA substrate that it is also capable of unwinding. The
generation of recombinant hMCMrepresents the development
of an important tool for understanding the mechanisms gov-
erning human DNA replication. This may ultimately improve
our ability tomanipulate cell proliferation and therefore design
useful and specific cancer treatments.
EXPERIMENTAL PROCEDURES
Expression and Purification of theMCM2–7Complex—PCR-
amplified MCM2–7 cDNAs (see primers in Table 2) were
cloned into Ek/LIC Duet vectors (Novagen). pET32-MCM2/7,
pRSF-MCM3/5, and pCDF-MCM4/6 were transformed into
E. coli Rosetta 2(DE3) cells (Novagen) and grown in a 75-liter
fermenter. The hMCM complex was bound to HIS-Select
cobalt affinity gel (Sigma) and passed over Superdex 200 gel fil-
tration and Mono Q columns. Fractions containing MCM2–7
were pooled; dialyzed against 25 mM HEPES (pH 8.0), 200 mM
sodium glutamate, 1 mM DTT, and 0.5 mM PMSF; flash-frozen
in small aliquots; and stored at80 °C. Site-directed mutagen-
esis of pET32-MCM2/7, pRSF-MCM3/5, and pCDF-MCM4/6
produced inactive point mutations in the Walker A motif for
each hMCM subunit (MCM2(K529E), MCM3(K351E), MCM4-
(K516E), MCM5(K387E), MCM6(K402E), and MCM7(K387E)).
ATPase-deficient mutant protein was produced and purified as
described for theWT type protein.
Western Blotting—Individual MCM subunits were con-
firmed by Western blotting the purified protein using primary
antibodies: anti-MCM2 (CS732) (18), anti-MCM3 (clone 3A2;
Medical & Biological Laboratories), anti-MCM4 (G-7; Santa
Cruz Biotechnology), anti-MCM5 (clone 33; BD Biosciences),
anti-MCM6 (clone 1/MCM6; BD Biosciences), and anti-
MCM7 (141.2; Santa Cruz Biotechnology).
ATPase Assays—Reactions were modified from Ref. 6 as fol-
lows. Reactions containing 30 mM K2HPO4/KH2PO4 buffer
(pH 8.5), 1 mM DTT, 100 g/ml BSA, 2% (v/v) glycerol, 10 mM
magnesium acetate, 1.5 nmol of unlabeled ATP, 3.08 pmol of
[-32P]ATP (800 Ci/mmol; ICN), 3.5 nM circular dsDNA
(pUC119 unless stated otherwise), and 176 nM protein were
assembled on ice.
DNAHelicase Substrate—OligonucleotideHS2 (Table 2)was
radiolabeled and annealed to oligonucleotide HS1 as described
(6).
Helicase Assays—Helicase reactions (4 nM 32P-labeled forked
substrate, MCM2–7 as indicated, 30 mM K2HPO4/KH2PO4
buffer (pH 8.5), 300 mM potassium glutamate, 1 mM DTT, 100
g/ml BSA, 2% (v/v) glycerol, 10 mMmagnesium acetate, and 4
mMATP)were incubated for 1 h at 37 °C and stoppedusing 0.25
volume of 80 mM EDTA, 0.8% (w/v) SDS, 40% (v/v) glycerol,
0.04% (w/v) xylene cyanol, and 0.04% (w/v) bromphenol blue.
Reaction products were separated on Tris borate/EDTA-11%
TABLE 1
Comparison of S. cerevisiae andH. sapiensMCMamino acid insertions
aa, amino acids.
MCM
S. cerevisiae
(aa)
H. sapiens
(aa)
aa difference
(S. cerevisiaeH. sapiens)
Insertion
locations
2 868 904 36 (4%) C
3 971 808 163 (20%) N, C
4 933 863 70 (8%) N
5 775 734 41 (6%) N
6 1017 821 196 (24%) N, C
7 845 719 126 (18%) N
TABLE 2
List of oligonucleotides used in this study
Oligonucleotide Sequence
MCM2
Forward gcgggcccggcctccatggcggaatcatcggaatccttcacc
Reverse gaggagaagcccggtcagaactgctgcaggatcattttcc
MCM3
Forward gcgggcccggccttcatggcgggtaccgtggtgctggac
Reverse gaggagaagcccggtcagatgaggaagatgatgccctcag
MCM4
Forward gcgggcccggccttcatgtcgtccccggcgtcgacccc
Reverse gaggagaagcccggtcagagcaagcgcacggtcttccc
MCM5
Forward gacgacgacaagatgtcgggattcgacgatcctggc
Reverse cgcgggcggccgtcacttgaggcggtagagaaccttgc
MCM6
Forward gacgacgacaagatggacctcgcggcggcagcgg
Reverse cgcgggcggccgtcaatcttcgagcaagtagttaggg
MCM7
Forward gacgacgacaagatggcactgaaggactacgcgctag
Reverse cgcgggcggccgtcagacaaaagtgatccgtgtccggg
HF150 cctggcgttacccaacttaatcgccttgcagcacatccccctttctttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt
HR80 tttttttttttttttttttttttttttttttttttgaaagggggatgtgctgcaaggcgattaagttgggtaacgccagg
HS1 gggacgcgtcggcctggcacgtcggccgctgcggccaggcacccgatggcgtttgtttgtttgtttgtttgttt
HS2 tttgtttgtttgtttgtttgtttgtttgtttgccgacgtgccaggccgacgcgtccc
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(w/v) polyacrylamide gels (2 h, 80 V). Gels were dried, imaged,
and quantified using a Bio-Rad Molecular Imager FX and
Quantity One software.
Binding of DuplexDNA to hMCM for EM—No-salt annealing
buffer (200mMHEPES (pH 8.0) and 5mM EDTA) was added to
1 M HF150 (150 bp) and 1 M HR80 (80 bp) (Table 2). DNA
was annealed at 95 °C for 3min, followed by cooling at 0.02 °C/s
to 23 °C. The temperature was kept at 23 °C for 1 min. hMCM
(8 g) was incubated with 60 nM duplex DNA in annealing
buffer (50 mM HEPES (pH 7.5), 2 mM DTT, 50 g/ml BSA, 10
mM magnesium acetate, and 4 mM ATP) for 60 min at 37 °C to
bind hMCM and duplex DNA. Samples were snap-frozen in
liquid nitrogen.
Electron Microscopy—hMCM samples were applied to con-
tinuous carbon grids and stained with freshly made methyl-
amine tungstate (pH 7). Data were collected on an FEI T12
microscope at a magnification of 67,000 and an accelerating
voltage of 120 kV, recorded on Kodak SO-163 films, and digi-
tized using a Zeiss Photoscan densitometer (14-m scanning
step, corresponding to 2.5 Å/pixel) before analysis.
Image Processing—Particle picking was carried out automat-
ically using Boxer (EMAN suite (19)). Analysis of the contrast
transfer function and correction was completed using CTFIT
(EMAN suite (19)). Image analysis was performed with
IMAGIC-5 (20). Images were normalized to the same S.D. and
bandpass-filtered. The low-resolution cutoff was 100 Å to
remove uneven background in particle images, and the high-
resolution cutoff was7 Å. Images were subjected to an align-
ment procedure, followed by statistical analysis. Alignment and
classification of images were performed as described previously
(20) and yielded classes representing characteristic views of the
molecule. Primary structural analysis of hMCM and hMCM
plus DNA complexes was performed using an ab initio
approach in which the orientations of the best 10–15 image
classes were determined by angular reconstitution using C1
startup. Three-dimensional maps were calculated using the
exact filtered backprojection algorithm (20). Structural analysis
was performed using several starting models with several dif-
ferent sets of image classes for ab initio reconstructions. The
first reconstructions were used for the following rounds of
alignment and classification of images. The structures of the
complexes were refined by an iterative procedure with the
number of classes gradually increased. The final reconstruction
for hMCM alone was calculated from the best 100 classes con-
taining 11 images each. For hMCM plus DNA, the final
reconstruction was calculated from the best 155 classes con-
taining 10 images each. Resolution of the map was assessed
using the 0.5 threshold of Fourier shell correlation (21), which
corresponds to 23Å.Domain fitting into the three-dimensional
map of hMCM and hMCM plus DNA complexes was per-
formed manually with UCSF Chimera (22). Illustrations were
generated using UCSF Chimera. Surface representations
(unless stated otherwise) are displayed at a threshold level of 3
(S.D. of densities within EM maps), which corresponds to
100% of the expectedmass at a specific protein density of 0.84
kDa/Å3.
RESULTS
Production of a Soluble hMCMComplex—To avoid potential
activity-inhibiting phosphorylation by kinases present in
eukaryotic expression systems, we coexpressed the hMCM2–7
proteins as a stable soluble complex in E. coli (Fig. 1A). The
complex was purified according to the scheme outlined in
Fig. 1B. The gel filtration elution profile for hMCM shows that
the peak purified is at 600 kDa (Fig. 1C). The presence of all
six hMCM subunits in the purified complex was demonstrated
by Western blotting using specific antibodies (Fig. 1D). Con-
sistent with our Western blot results, visualization of the com-
plex using Coomassie Blue-stained SDS-polyacrylamide gel
revealed the presence of some degradation products (con-
firmed by MS analysis) in addition to all six full-length hMCM
subunits (Fig. 1E). The MCM6 band is more intense than the
bands of the other subunits in the Coomassie Blue gel (Fig. 1E),
which could be due to differential staining based on protein
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FIGURE 1. Purification of a bacterially expressed hMCM complex. A, sche-
matic of the recombinant hMCM complex. Shown is the predicted arrange-
ment ofMCM2–7 subunits indicatingwhich subunits haveN-terminal affinity
tags to aid in protein purification. B, purification scheme for the recombinant
hMCM complex. C, gel filtration elution profile for the recombinant hMCM
complex. The elution fractions pooled are indicated by the asterisk. The pro-
tein markers thyroglobulin (669 kDa) and ferritin (440 kDa) are shown. D,
Western blot using antibodies specific to individual MCM subunits, showing
all six hMCM subunits in the purified complex. E, the purified hMCM complex
separatedby10% (w/v) SDS-PAGEandvisualizedbyCoomassie Blue staining.
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composition or a slight excess of uncomplexed MCM6 being
present in the soluble fraction after expression in E. coli. Typi-
cally, we produce 82.5 g of hMCM/liter of E. coli culture. A
complex harboring inactivating point mutations in the Walker
A motifs of each hMCM subunit (MCM2(K529E), Mcm3-
(K351E),MCM4(K516E),MCM5(K387E),MCM6(K402E), and
MCM7(K387E)) was produced in the same way.
ATP Hydrolysis Activity of hMCM—The purified WT
hMCMcomplex andATPase-deficientmutant complexeswere
tested for their ability to hydrolyze ATP in the presence and
absence of a series of DNA substrates (at hMCM hexamer/
DNAmolar ratios ranging from110:1 to 3.8:1) (Fig. 2A). hMCM
exhibited ATP hydrolysis, which was not increased by the addi-
tion of DNA. High concentrations (46 nM) of closed circular
dsDNA inhibited ATP hydrolysis by 50% compared with
lower concentrations of dsDNA, possibly due to a substrate
competition effect preventing theMCMproteins from forming
a productive complex. A similar but smaller effect was observed
for closed circular ssDNA. A forked DNA substrate had a neg-
ligible effect on hydrolysis activity at the concentrations tested.
Subsequent ATP hydrolysis assays were carried out in the pres-
ence of 3.5 nM dsDNA.
On the basis of previous reports of specific salt requirements
for yeast MCM activity in vitro (17), we examined the ability of
hMCM to hydrolyze ATP in the presence of sodium chloride,
sodium glutamate, potassium chloride, and potassium gluta-
mate (Fig. 2B). Increased sodium chloride concentrations
resulted in a statistically significant decrease in ATP hydrolysis.
A similar effect was observed for sodium glutamate. The addi-
tion of 50 mM potassium chloride resulted in a pronounced
inhibition of ATPase activity. Strikingly, the presence of 300
mM potassium glutamate, twice the physiological salt concen-
tration, had no effect on ATPase activity (Fig. 2B). As expected,
increasing concentrations of hMCM resulted in increased ATP
hydrolysis (Fig. 2C). The addition of 20 mM EDTA significantly
reduced ATP hydrolysis by hMCM, as did replacing the WT
proteinwith theATPase-deficientmutant complex (Fig. 2C), as
expected fromprevious studies in S. cerevisiae (5, 23). Using the
optimum assay conditions identified (3.5 nM dsDNA, 300 mM
potassium glutamate, and 176 nM hMCM), we measured the
rate of ATP hydrolysis for WT and mutant hMCM (Fig. 2D).
The maximum rate of ATP hydrolysis was 16.7 pmol of ADP
released per min/pmol ofWT hMCM compared with 3.9 pmol
of ADP released per min/pmol of mutant hMCM.
ATP-dependent DNA Unwinding by hMCM—We tested our
purified recombinant hMCM complexes for DNA helicase
activity using a forked DNA substrate in the presence or
absence of ATP. WT hMCM exhibited a protein concentra-
tion- and ATP-dependent DNA unwinding activity (Fig. 3).
With WT hMCM, we observed 38 and 50% displacement by
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FIGURE 2. WT hMCM possesses ATPase activity. A, 46 nM closed circular ssDNA (hMCM hexamer/DNA molar ratio of 3.8:1) reduced ATP hydrolysis by
one-third, and closed circular dsDNA reduced ATP hydrolysis by50%. ForkedDNA had little overall effect. Statistics compare the labeled barswith 0 nMDNA.
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The data in A–C are mean values of three replicates, and the data in D are mean values of two assays. Error bars show S.D.
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176 M and 352 nM hMCM2–7, respectively (Fig. 3), broadly
comparable with the reported 52% displacement by 110 nM
yeast Mcm2–7 (17). Under conditions in which ATP could not
be hydrolyzed, i.e. either WT hMCM in the absence of ATP or
mutant hMCM in the presence of ATP, helicase activity was
substantially reduced (Fig. 3B), consistent with ATP hydrolysis
being required for helicase activity.
EM Structure of Recombinant hMCM—The structures of the
purified hMCMcomplex alone and bound to forkedDNAwere
obtained by EM of negatively stained particles. Structures were
obtained using a single-particle approach with C1 symmetry
(Fig. 4). Our results reveal that the complex forms ring-shaped
hexamers with a diameter of 145 Å and a height of 120 Å (Fig.
4C). Our asymmetric reconstructions (Fig. 4) clearly show that
the complexes contain six subunits. However, the resolution
does not allow us to identify the position of each subunit.When
observed in the presence of forked DNA (Fig. 4C, lower row),
the hMCM structure has a different conformation, with amore
defined two-tiered hexameric shape and amore obviously open
central cavity. The atomic model of the hexamer of Sulfolobus
solfataricusMCM (Protein Data Bank ID 3F9V) fits neatly into
our reconstruction (Fig. 5).
DISCUSSION
ATP hydrolysis has been demonstrated forMCM complexes
derived fromarchaea (5) and eukaryotes (23, 24).We found that
the addition of DNA did not stimulate ATP hydrolysis by puri-
fied hMCM. This is consistent with reports of S. cerevisiae
Mcm2–7, in which DNA did not stimulate ATP hydrolysis (23,
25). It is worth noting that this is in contrast to the Mcm4-
Mcm6-Mcm7 subcomplex, which is stimulated by DNA (26,
27). In agreement with observations from archaeal MCM pro-
teins (5), high concentrations of dsDNAwere in fact inhibitory.
With respect to salt sensitivity, 50 mM potassium chloride
strongly inhibited the ATPase activity of hMCM, whereas
potassium glutamate, even at a concentration of 300 mM, had
no such effect. These findings are consistent with results
reported for the DNA helicase activity of S. cerevisiae MCM
(17).
Binding and hydrolysis of ATP by MCM purified from
S. cerevisiae have recently been shown to be required for Cdt1
release and double-hexamer formation (28), with the ATPase
sites of different MCM subunits implicated in different stages
of MCM loading and activation (29). The interface between
subunits 2 and 5 of the S. cerevisiae Mcm2–7 complex is
thought to function as an ATP-dependent “gate,” the opening
of which enables the toroidal complex to be loaded onto topo-
logically closed DNA (17). The recombinant hMCM complex
produced here is an important tool to analyze the loading and
activation of the human complex in light of this finding.
Robust ATP-dependent DNA helicase activities were first
demonstrated using archaeal homohexamers (5). LimitedDNA
helicase activity was originally demonstrated for a hexameric
complex purified from HeLa cells that contained hMCM sub-
units 4, 6, and 7, probably as a dimer of trimers (24). This activ-
ity was inhibited by the addition of mouse MCM2 (30). The
salt-sensitive DNA helicase activity of a heterohexameric
Mcm2–7 complex was first demonstrated using S. cerevisiae
proteins purified after baculovirus expression (17), and DNA
unwinding activity of higher eukaryotic MCM complexes has
been observed with the Cdc45-MCM-GINS complex from
Drosophila (15). Here, we described the first demonstration of
helicase activity for the hMCM2–7 complex.
Our results show that ATP hydrolysis is a requirement for
DNA helicase activity. The negligible unwinding and ATPase
activities in the mutant hMCM assays suggest that the mutant
andWT protein preparations were both free from contaminat-
ing E. coli helicases/ATPases. Under ATPase null conditions
(either no ATP or mutant hMCM), a large proportion of the
helicase substrate migrated more slowly on native polyacryl-
amide gel. Similar mobility shift effects were observed previ-
ously for theMethanothermobacter thermautotrophicusMCM
complex when samples were incubated on ice (6). This suggests
that the hMCMprotein binds to the substrate in the absence of
ATP (or ATP hydrolysis) but cannot unwind it. This is consis-
FIGURE 3. Recombinant hMCM displays DNA helicase activity. A, a forked
DNA substratewas incubatedwith increasing concentrations of hMCM in the
absence or presence of ATP. Heat-denatured boiled substrate () and no-pro-
tein lanes were included as controls. The arrow indicates the position of dis-
placed substrate, and the asterisk indicates substrate with unusual mobility,
perhaps indicating that hMCM that is bound to DNA. B, the amount of single-
stranded substrate in each reaction was quantified as a percentage of the
boiled substrate control. The data shown are mean values for four indepen-
dent assays, an example of which is shown in A. Error bars indicate S.E. Statis-
tics compare labeled lanes with 352 nM hMCM plus ATP. ***, p  0.00013;
**, p 0.0014.
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tent with the idea that ATP hydrolysis is not required for DNA-
protein interactions but is required for DNA unwinding (31).
Overall, these results indicate that the recombinant hMCM
complex exhibits DNA helicase activity and that post-transla-
tional modifications to hMCM or accessory proteins such as
Cdc45 and GINS are not required for the unwinding of naked
DNA. The presence of Cdc45 and GINS may be required only
for remodeling or unwinding DNA packaged into chromatin.
The size and shape of our hMCM complex are consistent
with the organization of oligomeric complexes reported for
MCM from other eukaryotes (32, 33). Analysis of a population
of Drosophila Mcm2–7 complexes revealed that they exist in
two different states: a planar notched ring and an open spiral
shape (32). Reconstructions of Mcm2–7 from Encephalitozoon
cuniculi suggest that this Mcm2–7 complex is naturally found
in the open spiral shape (34). Our reconstruction of the human
complex ismore similar to the notched ring, similar to S. cerevi-
siae (35), but this does not preclude the existence of a minority
of spiral-shaped complexes in our sample.
Interestingly, the conformation taken by hMCM in the pres-
ence of DNA is somewhat similar to that which has been
reported for S. cerevisiaeMcm2–7 in the absence of DNA (36).
One possible reason for the differences observed between the
yeast and human proteins in the absence of DNA could be the
differences in their primary sequences (outlined in Table 1).
The prominent projection that appears on the C-terminal sur-
face of one of the hMCM subunits in the presence of DNA (Fig.
4C, red circle) could be either the bound 45-bp double-stranded
portion of the DNA substrate (as ssDNA is too small to be
clearly visualized at this resolution) or a protein domain dis-
placed by the presence of the DNA, such as a flexible C-termi-
nal domain. Further work is required to determine which
hMCM subunit binds DNA under these conditions.
hMCM is an important factor in cell proliferation and there-
fore, by extension, cancer development. The ability to produce
significant quantities of hMCMfor analysis is an important step
forward. Our biochemical findings show that the recombinant
complex is active in vitro, and our structural studies show that
its conformation is altered when bound to DNA. Our system
enables the targetedmanipulation of individual proteins within
the hMCMcomplex, providing the potential to address in detail
FIGURE 4. A, hMCM classes and reprojections used in the final reconstruction for hMCM alone. B, same as in A for hMCM plus DNA. C, negative stain,
single-particle asymmetric EM three-dimensional reconstruction of hMCM to 23 Å resolution. Upper row, hMCM alone (blue) from three different aspects. The
complex undergoes a conformational changewhen hMCM is bound to forkedDNA (middle row, green). The red circle highlights protrusion thought to beDNA
binding to hMCM. Sizes are indicated in angstroms. Lower row, schematic representation of hMCM subunit configuration.
FIGURE 5. The crystal structure of S. solfataricusMCM fits into our recon-
structions. Shown is hMCM alone (blue) and bound to forked DNA (green)
fittedwith the nearly full-length S. solfataricusMCM crystal structure (Protein
Data Bank ID 3F9V) (8). The full-length hMCM structure (left) and a slice
through hMCM (right) show a central cavity in both reconstructions.
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the important differences between individual subunits in
the hMCM heterohexamer. It also provides the potential to
develop screens for clinically relevant hMCM inhibitors.
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